Reviewing OptimizeRx (NASDAQ:OPRX) and Healthcare Triangle (NASDAQ:HCTI)

Healthcare Triangle (NASDAQ:HCTI – Get Free Report) and OptimizeRx (NASDAQ:OPRX – Get Free Report) are both small-cap healthcare companies, but which is the better business? We will compare the two businesses based on the strength of their profitability, valuation, institutional ownership, dividends, risk, analyst recommendations and earnings.

Risk & Volatility

Healthcare Triangle has a beta of 1.18, meaning that its stock price is 18% more volatile than the S&P 500. Comparatively, OptimizeRx has a beta of 1.2, meaning that its stock price is 20% more volatile than the S&P 500.

Earnings & Valuation

This table compares Healthcare Triangle and OptimizeRx”s gross revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Healthcare Triangle $25.67 million 0.10 -$9.48 million ($166.19) -0.02
OptimizeRx $109.43 million 1.16 $5.13 million $0.25 26.80

OptimizeRx has higher revenue and earnings than Healthcare Triangle. Healthcare Triangle is trading at a lower price-to-earnings ratio than OptimizeRx, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares Healthcare Triangle and OptimizeRx’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Healthcare Triangle -45.37% -54.80% -22.80%
OptimizeRx 5.33% 9.58% 7.47%

Analyst Ratings

This is a breakdown of recent ratings and recommmendations for Healthcare Triangle and OptimizeRx, as reported by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Healthcare Triangle 1 0 0 0 1.00
OptimizeRx 0 3 6 0 2.67

OptimizeRx has a consensus price target of $11.21, suggesting a potential upside of 67.38%. Given OptimizeRx’s stronger consensus rating and higher possible upside, analysts plainly believe OptimizeRx is more favorable than Healthcare Triangle.

Institutional and Insider Ownership

0.3% of Healthcare Triangle shares are owned by institutional investors. Comparatively, 76.5% of OptimizeRx shares are owned by institutional investors. 0.1% of Healthcare Triangle shares are owned by insiders. Comparatively, 7.5% of OptimizeRx shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Summary

OptimizeRx beats Healthcare Triangle on 14 of the 14 factors compared between the two stocks.

About Healthcare Triangle

(Get Free Report)

Healthcare Triangle, Inc. provides technology and consulting services to healthcare and life sciences organizations. Its work includes helping clients modernize cloud systems, manage and analyze data, connect disparate health information systems, and address cybersecurity and regulatory-compliance needs. The company offers solutions under the CloudEz, DataEz and InteropX names, covering cloud services, data management and interoperability. It also provides implementation, consulting and ongoing technology support.

About OptimizeRx

(Get Free Report)

OptimizeRx is a healthcare technology company that connects life sciences companies with healthcare professionals and patients through digital communications. Its platform uses channels such as electronic health records and other clinical workflows to deliver relevant information at the point of care. The company’s services support programs for medication access and affordability, patient education and engagement, and communication between healthcare providers and life sciences organizations. OptimizeRx also provides tools intended to help life sciences companies reach clinicians and patients through digital channels.

Receive News & Ratings for Healthcare Triangle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthcare Triangle and related companies with MarketBeat.com's FREE daily email newsletter.